GGLL
Price
$115.15
Change
-$5.10 (-4.24%)
Updated
Jun 10 closing price
Net Assets
1.28B
Intraday BUY SELL Signals
QULL
Price
$64.01
Change
-$0.17 (-0.26%)
Updated
Jun 9 closing price
Net Assets
40.87M
Intraday BUY SELL Signals
SPXL
Price
$249.67
Change
-$12.39 (-4.73%)
Updated
Jun 10 closing price
Net Assets
6.23B
Intraday BUY SELL Signals
Interact to see
Advertisement

GGLL or QULL or SPXL

Header iconGGLL vs QULL vs SPXL Comparison
Open Charts GGLL vs QULL vs SPXLBanner chart's image
GGLL vs QULL vs SPXL Comparison Chart in %
View a ticker or compare two or three

Which ETF would AI Choose? Direxion Daily GOOGL Bull 2X Shares (GGLL) vs. ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) vs. Direxion Daily S&P 500 Bull 3X Shares (SPXL)

Key Takeaways

  • GGLL offers 2x daily leveraged exposure to a single stock, GOOGL, providing concentrated communication services tilt but highest single-issuer risk.
  • QULL delivers 2x leveraged exposure to the sector-neutral quality factor via ~121 large- and mid-cap U.S. stocks, balancing quality traits like profitability across sectors with moderate diversification.
  • SPXL targets 3x daily leverage on the broad S&P 500 Index with ~500 holdings, offering widest diversification but amplified volatility from higher leverage.
  • Expense ratios are comparable: GGLL at 0.96%, QULL's tracking fee at 0.95%, SPXL net at 0.84% (gross 0.95%), favoring cost efficiency across all for short-term tactical use.
  • All feature daily or quarterly resets amplifying compounding effects, suiting short-term trades over long-term holds; SPXL shows lowest concentration risk, GGLL the highest.
  • In tech-driven markets, GGLL and SPXL exhibit higher sensitivity to growth sectors, while QULL's quality focus provides relative stability in volatile cycles.

Introduction

These leveraged ETFs—GGLL, QULL, and SPXL—appeal to tactical investors seeking amplified exposure amid evolving U.S. equity dynamics. GGLL provides targeted 2x daily leverage on Alphabet's Class A shares (GOOGL), a tech leader in advertising and cloud. QULL offers 2x leveraged access to quality large- and mid-cap U.S. equities via a sector-neutral index, emphasizing profitability and stability. SPXL delivers 3x daily leverage on the S&P 500, capturing broad large-cap performance. Comparing them highlights trade-offs in concentration, diversification, leverage intensity, and factor tilts, relevant as investors navigate tech momentum, quality resilience, and macroeconomic shifts in recent market cycles.

Direxion Daily GOOGL Bull 2X Shares (GGLL) Overview

The Direxion Daily GOOGL Bull 2X Shares (GGLL) is a leveraged ETF seeking daily investment results, before fees and expenses, equal to 200% of the performance of Alphabet Inc. Class A shares (GOOGL). Launched in 2022 by Direxion, it uses derivatives like swaps for leverage, with ~10-16 holdings primarily cash equivalents (e.g., Dreyfus Govt Cash Man Ins ~34-39%, Goldman Finl Sq Trsry ~16-27%) and swap/direct exposure to GOOGL (~10-12%). Sector allocation is 100% communication services via Alphabet's digital ecosystem. The gross/net expense ratio is 0.96%. As a non-diversified, single-stock leveraged fund, it rebalances daily, amplifying volatility and compounding effects, ideal for short-term bullish bets on GOOGL but exposed to company-specific risks like regulatory scrutiny.

ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) Overview

The ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL), issued by UBS in 2021, is an exchange-traded note providing 2x leveraged long exposure to the compounded quarterly performance of the MSCI USA Sector Neutral Quality GR USD Index, net of a 0.95% annual tracking fee (plus financing costs). This index selects ~121 large- and mid-cap U.S. equities from the MSCI USA Index exhibiting superior quality (e.g., high ROE, earnings stability) relative to sector peers, maintaining sector neutrality. As an ETN, QULL has no direct holdings—exposure is unsecured debt obligation of UBS. Top constituents typically include NVDA (~6.5%), AAPL (~6.3%), MSFT (~5%). It rebalances quarterly, offering factor-driven diversification with lower concentration than single-stock peers.

Direxion Daily S&P 500 Bull 3X Shares (SPXL) Overview

Direxion Daily S&P 500 Bull 3X Shares (SPXL), launched in 2008, seeks 300% daily leveraged performance of the S&P 500 Index before fees (net expense ratio 0.84%, gross 0.95%). This passive ETF holds ~500+ securities mirroring the index of large-cap U.S. leaders, using swaps and index components. Top holdings reflect index weights: NVDA (~5-7%), AAPL (~4-7%), MSFT (~3-5%), AMZN, GOOGL. Sector breakdown: Information Technology ~33%, Financials ~13%, Communication Services ~11%, Consumer Discretionary ~10%, Health Care ~10%. Daily rebalancing heightens volatility, positioning it for broad market upside with diversified risk relative to single-stock focus.

Industry and Thematic Landscape

Large-cap U.S. equities dominate amid AI advancements, cloud expansion, and digital transformation, driving capital flows into technology and communication services. Macro drivers like interest rate trajectories, inflation moderation, and productivity gains from tech bolster S&P 500 components, while quality factors—emphasizing stable earnings and balance sheets—thrive in uncertainty. Regulatory shifts, including antitrust probes on big tech and data privacy rules, pose risks to concentrated exposures. Geopolitical tensions and supply chain dynamics impact earnings trends, particularly for semiconductors and consumer discretionary. Sector risks include valuation stretches in IT and cyclical sensitivity in financials, influencing leveraged products sensitive to these trends over recent market cycles.

Performance and Positioning Comparison

In recent weeks and months, SPXL's 3x leverage has amplified broad S&P 500 uptrends, outperforming in momentum phases but with deeper drawdowns during volatility spikes due to compounding. GGLL tracks 2x GOOGL moves, shining in tech rallies tied to AI and advertising but vulnerable to stock-specific lulls, exhibiting higher relative volatility than diversified peers. QULL's quality tilt and sector neutrality have shown trend consistency, with shallower drawdowns in choppy markets, though quarterly compounding tempers daily extremes. Structural differences explain variances: GGLL's single-stock concentration heightens idiosyncratic risk; QULL mitigates via factor selection; SPXL's breadth reduces single-name exposure but magnifies macro sensitivity. All display elevated volatility versus unleveraged benchmarks.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization (market cap), technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, empowering data-driven decisions in dynamic environments. Explore it today to uncover hidden gems across sectors.

Tickeron AI Verdict

Tickeron’s AI favors SPXL for its superior diversification across ~500 holdings, cost efficiency at 0.84% net expense ratio, and stable momentum in broad uptrends, offering a 65% probability of relative outperformance over multi-week horizons based on structural breadth and risk-adjusted positioning. QULL ranks second for quality resilience, while GGLL trails due to single-stock concentration despite tech tilt.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 6.23B vs. GGLL (1.28B) and QULL (40.9M). GGLL has a higher annual dividend yield than SPXL and QULL: GGLL (19.650) vs SPXL (13.440) and QULL (12.653). GGLL was incepted earlier than QULL and SPXL: GGLL (4 years) vs QULL (5 years) and SPXL (18 years).
GGLLQULLSPXL
Gain YTD19.65012.65313.440
Net Assets1.28B40.9M6.23B
Total Expense Ratio0.96N/A0.84
Turnover0.00N/A71.00
Yield3.330.000.52
Fund Existence4 years5 years18 years
TECHNICAL ANALYSIS
Technical Analysis
GGLLQULLSPXL
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
90%
Bullish Trend 8 days ago
86%
Bullish Trend 10 days ago
90%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GGLL
Daily Signal:
Gain/Loss:
QULL
Daily Signal:
Gain/Loss:
SPXL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGEN3.880.17
+4.72%
Precigen
KYMR78.211.30
+1.69%
Kymera Therapeutics
RADX4.310.06
+1.41%
Radiopharm Theranostics Limited
UCFI5.51N/A
N/A
CN Healthy Food Tech Group Corp.
AMGN337.73-6.83
-1.98%
Amgen